124 related articles for article (PubMed ID: 34999588)
1. Comorbidities as Risk Factors for Severe Disease in Hospitalized Elderly COVID-19 Patients by Different Age-Groups in Japan.
Asai Y; Nomoto H; Hayakawa K; Matsunaga N; Tsuzuki S; Terada M; Ohtsu H; Kitajima K; Suzuki K; Suzuki T; Nakamura K; Morioka S; Saito S; Saito F; Ohmagari N
Gerontology; 2022; 68(9):1027-1037. PubMed ID: 34999588
[TBL] [Abstract][Full Text] [Related]
2. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
3. Association of pre-existing comorbidities with mortality and disease severity among 167,500 individuals with COVID-19 in Canada: A population-based cohort study.
Ge E; Li Y; Wu S; Candido E; Wei X
PLoS One; 2021; 16(10):e0258154. PubMed ID: 34610047
[TBL] [Abstract][Full Text] [Related]
4. Clinical Epidemiology of Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) in Japan: Report of the COVID-19 Registry Japan.
Matsunaga N; Hayakawa K; Terada M; Ohtsu H; Asai Y; Tsuzuki S; Suzuki S; Toyoda A; Suzuki K; Endo M; Fujii N; Suzuki M; Saito S; Uemura Y; Shibata T; Kondo M; Izumi K; Terada-Hirashima J; Mikami A; Sugiura W; Ohmagari N
Clin Infect Dis; 2021 Dec; 73(11):e3677-e3689. PubMed ID: 32986793
[TBL] [Abstract][Full Text] [Related]
5. Association of excess visceral fat and severe illness in hospitalized COVID-19 patients in Japan: a retrospective cohort study.
Goto Y; Nagamine Y; Hanafusa M; Kawahara T; Nawa N; Tateishi U; Ueki Y; Miyamae S; Wakabayashi K; Nosaka N; Miyazaki Y; Tohda S; Fujiwara T
Int J Obes (Lond); 2024 May; 48(5):674-682. PubMed ID: 38233538
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for severity on admission and the disease progression during hospitalisation in a large cohort of patients with COVID-19 in Japan.
Terada M; Ohtsu H; Saito S; Hayakawa K; Tsuzuki S; Asai Y; Matsunaga N; Kutsuna S; Sugiura W; Ohmagari N
BMJ Open; 2021 Jun; 11(6):e047007. PubMed ID: 34130961
[TBL] [Abstract][Full Text] [Related]
7. Development of a Risk Prediction Score to Identify High-Risk Groups for the Critical Coronavirus Disease 2019 (COVID-19) in Japan.
Fukushima K; Yamada Y; Fujiwara S; Tanaka M; Kobayashi T; Yajima K; Tanaka K; Sekiya N; Imamura A
Jpn J Infect Dis; 2021 Jul; 74(4):344-351. PubMed ID: 33390431
[TBL] [Abstract][Full Text] [Related]
8. Mortality-associated Risk Factors in Hospitalized COVID-19 Patients in Japan: Findings of the CLOT-COVID Study.
Takeyama M; Yachi S; Nishimoto Y; Tsujino I; Nakamura J; Yamamoto N; Nakata H; Ikeda S; Umetsu M; Aikawa S; Hayashi H; Satokawa H; Okuno Y; Iwata E; Ogihara Y; Ikeda N; Kondo A; Iwai T; Yamada N; Ogawa T; Kobayashi T; Mo M; Yamashita Y
J Epidemiol; 2023 Mar; 33(3):150-157. PubMed ID: 36372435
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for hospitalization or mortality for COVID-19 in patients with rheumatic diseases: Results of a nationwide JCR COVID-19 registry in Japan.
Oku K; Kimoto Y; Horiuchi T; Yamamoto M; Kondo Y; Okamoto M; Atsumi T; Takeuchi T
Mod Rheumatol; 2023 Jul; 33(4):768-776. PubMed ID: 36066189
[TBL] [Abstract][Full Text] [Related]
10. Comorbidities associated with COVID-19 mortality in adults in Lima, Peru: a retrospective cohort study.
Soto-Cabezas MG; Reyes-Vega MF; Soriano-Moreno AN; Ordoñez-Ibargüen L; Martel KS; Flores-Jaime N; Chirinos-Saire J; Velásquez JP; Munayco CV
Rev Peru Med Exp Salud Publica; 2023; 40(2):132-140. PubMed ID: 38232259
[TBL] [Abstract][Full Text] [Related]
11. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area.
Richardson S; Hirsch JS; Narasimhan M; Crawford JM; McGinn T; Davidson KW; ; Barnaby DP; Becker LB; Chelico JD; Cohen SL; Cookingham J; Coppa K; Diefenbach MA; Dominello AJ; Duer-Hefele J; Falzon L; Gitlin J; Hajizadeh N; Harvin TG; Hirschwerk DA; Kim EJ; Kozel ZM; Marrast LM; Mogavero JN; Osorio GA; Qiu M; Zanos TP
JAMA; 2020 May; 323(20):2052-2059. PubMed ID: 32320003
[TBL] [Abstract][Full Text] [Related]
12. Severe Acute Respiratory Syndrome by SARS-CoV-2 Infection or Other Etiologic Agents Among Brazilian Indigenous Population: An Observational Study from the First Year of Coronavirus Disease (COVID)-19 Pandemic.
Sansone NMS; Boschiero MN; Ortega MM; Ribeiro IA; Peixoto AO; Mendes RT; Marson FAL
Lancet Reg Health Am; 2022 Apr; 8():100177. PubMed ID: 35018359
[TBL] [Abstract][Full Text] [Related]
13. Effects of Comorbidities on the Elderly Patients with COVID-19: Clinical Characteristics of Elderly Patients Infected with COVID-19 from Sichuan, China.
Dai SP; Zhao X; Wu JH
J Nutr Health Aging; 2021; 25(1):18-24. PubMed ID: 33367458
[TBL] [Abstract][Full Text] [Related]
14. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study.
Petrilli CM; Jones SA; Yang J; Rajagopalan H; O'Donnell L; Chernyak Y; Tobin KA; Cerfolio RJ; Francois F; Horwitz LI
BMJ; 2020 May; 369():m1966. PubMed ID: 32444366
[TBL] [Abstract][Full Text] [Related]
15. Clinical Characteristics and Outcomes of 74 Patients With Severe or Critical COVID-19.
Li J; Xu G; Yu H; Peng X; Luo Y; Cao C
Am J Med Sci; 2020 Sep; 360(3):229-235. PubMed ID: 32653160
[TBL] [Abstract][Full Text] [Related]
16. Clinical Characteristics and Risk Factors for Mortality in Very Old Patients Hospitalized With COVID-19 in Spain.
Ramos-Rincon JM; Buonaiuto V; Ricci M; Martín-Carmona J; Paredes-Ruíz D; Calderón-Moreno M; Rubio-Rivas M; Beato-Pérez JL; Arnalich-Fernández F; Monge-Monge D; Vargas-Núñez JA; Acebes-Repiso G; Mendez-Bailon M; Perales-Fraile I; García-García GM; Guisado-Vasco P; Abdelhady-Kishta A; Pascual-Pérez MD; Rodríguez-Fernández-Viagas C; Montaño-Martínez A; López-Ruiz A; Gonzalez-Juarez MJ; Pérez-García C; Casas-Rojo JM; Gómez-Huelgas R;
J Gerontol A Biol Sci Med Sci; 2021 Feb; 76(3):e28-e37. PubMed ID: 33103720
[TBL] [Abstract][Full Text] [Related]
17. Characteristics and outcomes of patients with COVID-19 admitted to hospital and intensive care in the first phase of the pandemic in Canada: a national cohort study.
Murthy S; Archambault PM; Atique A; Carrier FM; Cheng MP; Codan C; Daneman N; Dechert W; Douglas S; Fiest KM; Fowler R; Goco G; Gu Y; Guerguerian AM; Hall R; Hsu JM; Joffe A; Jouvet P; Kelly L; Kho ME; Kruisselbrink RJ; Kumar D; Kutsogiannis DJ; Lamontagne F; Lee TC; Menon K; O'Grady H; O'Hearn K; Ovakim DH; Pharand SG; Pitre T; Reel R; Reeve B; Rewa O; Richardson D; Rishu A; Sandhu G; Sarfo-Mensah S; Shadowitz E; Sligl W; Solomon J; Stelfox HT; Swanson A; Tessier-Grenier H; Tsang JLY; Wood G;
CMAJ Open; 2021; 9(1):E181-E188. PubMed ID: 33688026
[TBL] [Abstract][Full Text] [Related]
18. Clinical characteristics and prognosis of immunosuppressed inpatients with COVID-19 in Japan.
Nomoto H; Suzuki S; Asai Y; Hayakawa K; Gatanaga H; Terada M; Suzuki K; Ohtsu H; Toyoda A; Ohmagari N
J Infect Chemother; 2022 Feb; 28(2):224-231. PubMed ID: 34776348
[TBL] [Abstract][Full Text] [Related]
19. COVID-19 Outcomes Among Patients With Cancer: Observations From the University of California Cancer Consortium COVID-19 Project Outcomes Registry.
Borno HT; Kim MO; Hong JC; Yousefi S; Lin A; Tolstykh I; Zhang S; McKay RR; Harismendy O; Cinar P; Rugo H; Koshkin VS; Rabow M; Wang C; Bailey A; Small EJ
Oncologist; 2022 May; 27(5):398-406. PubMed ID: 35348771
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics and outcomes in elderly with coronavirus disease 2019 in Beijing, China: a retrospective cohort study.
Zhang W; Hou W; Jin R; Liang L; Xu B; Hu Z
Intern Emerg Med; 2021 Jun; 16(4):875-882. PubMed ID: 33040272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
